# RELAXaHEAD for Headache Patients (Phase III)

> **NCT06077838** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 356 (estimated)

## Conditions studied

- Migraine

## Interventions

- **BEHAVIORAL:** RELAXaHEAD Smartphone App Version 1
- **BEHAVIORAL:** RELAXaHEAD Smartphone App Version 2

## Key facts

- **NCT ID:** NCT06077838
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-08
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 356 (ESTIMATED)
- **Last updated:** 2025-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06077838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06077838, "RELAXaHEAD for Headache Patients (Phase III)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06077838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*